TY - JOUR
T1 - Thymoma-associated chronic diarrhea
T2 - A case of autoimmune enteropathy
AU - Riquelme, Patricio
AU - Tisch, Alison H.
AU - Liang, Ying
AU - Lowe, Anson W.
AU - Colevas, Alexander D.
AU - Wakelee, Heather A.
N1 - Publisher Copyright:
© 2015 Elsevier Ltd.
Copyright:
Copyright 2015 Elsevier B.V., All rights reserved.
PY - 2015
Y1 - 2015
N2 - Thymomas are tumors arising from thymic epithelial cells that are frequently associated with autoimmune conditions. One such disorder, autoimmune enteropathy, is an uncommon autoimmune process found in patients with thymoma that is characterized by chronic diarrhea (>6 weeks duration), malabsorption, and characteristic small intestinal histopathology. The presence of anti-enterocyte or anti-goblet cell antibodies supports the diagnosis of autoimmune. As this is a relatively uncommon disorder, treatment options have not been well studied. We report the case of a 35-year-old Caucasian male with recurrent thymoma that subsequently developed autoimmune enteropathy as confirmed by symptoms, biopsy and serologies. Prednisone and octreotide, which have previously been shown to treat recurrent thymoma, were used to successfully treat his autoimmune enteropathy and recurrent thymoma, leading to resolution of diarrhea, subsequent weight gain, and radiographic confirmation of regression of metastatic thymoma. Autoimmune enteropathy should be considered in the differential diagnosis of patients with thymoma presenting with intractable diarrhea and weight loss. The use of prednisone and octreotide may be helpful in treating both conditions.
AB - Thymomas are tumors arising from thymic epithelial cells that are frequently associated with autoimmune conditions. One such disorder, autoimmune enteropathy, is an uncommon autoimmune process found in patients with thymoma that is characterized by chronic diarrhea (>6 weeks duration), malabsorption, and characteristic small intestinal histopathology. The presence of anti-enterocyte or anti-goblet cell antibodies supports the diagnosis of autoimmune. As this is a relatively uncommon disorder, treatment options have not been well studied. We report the case of a 35-year-old Caucasian male with recurrent thymoma that subsequently developed autoimmune enteropathy as confirmed by symptoms, biopsy and serologies. Prednisone and octreotide, which have previously been shown to treat recurrent thymoma, were used to successfully treat his autoimmune enteropathy and recurrent thymoma, leading to resolution of diarrhea, subsequent weight gain, and radiographic confirmation of regression of metastatic thymoma. Autoimmune enteropathy should be considered in the differential diagnosis of patients with thymoma presenting with intractable diarrhea and weight loss. The use of prednisone and octreotide may be helpful in treating both conditions.
KW - Autoimmune enteropathy
KW - Diarrhea
KW - Malabsorption
KW - Octreotide
KW - Prednisone
KW - Thymoma
UR - http://www.scopus.com/inward/record.url?scp=84947928324&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84947928324&partnerID=8YFLogxK
U2 - 10.1016/j.ctrc.2015.04.002
DO - 10.1016/j.ctrc.2015.04.002
M3 - Article
AN - SCOPUS:84947928324
SN - 2213-0896
VL - 4
SP - 46
EP - 49
JO - Cancer Treatment and Research Communications
JF - Cancer Treatment and Research Communications
ER -